Page last updated: 2024-09-05

sorafenib and gsk343

sorafenib has been researched along with gsk343 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(gsk343)
Trials
(gsk343)
Recent Studies (post-2010) (gsk343)
6,5207305,25143043

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)gsk343 (IC50)
Polycomb protein EEDHomo sapiens (human)0.122
Histone-binding protein RBBP4Homo sapiens (human)0.122
Polycomb protein SUZ12Homo sapiens (human)0.122
Histone-lysine N-methyltransferase EZH2Homo sapiens (human)1.0255
Histone-binding protein RBBP7Homo sapiens (human)0.004
Zinc finger protein AEBP2Homo sapiens (human)0.24
Histone-lysine N-methyltransferase EZH1Homo sapiens (human)0.24

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsiao, HH; Liu, TP; Lo, HL; Wei, LS; Yang, PM1

Other Studies

1 other study(ies) available for sorafenib and gsk343

ArticleYear
S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells.
    Anti-cancer drugs, 2015, Volume: 26, Issue:2

    Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; Cell Survival; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Gene Knockdown Techniques; Hep G2 Cells; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Indazoles; Niacinamide; Phenylurea Compounds; Polycomb Repressive Complex 2; Pyridones; S-Adenosylmethionine; Sorafenib

2015